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Objectives: In laparoscopic liver resection, multiple options for parenchymal transection techniques
exist; however, none have emerged as superior. The aim of this study was to compare operative
characteristics and outcomes between bipolar compression and ultrasonic devices used for parenchymal
transection during laparoscopic liver resection.
Methods: A review of a prospective hepatopancreatobiliary database from December 2002 to August
2009 identified 54 patients who underwent laparoscopic liver resection with parenchymal division using
either a bipolar compression (n = 35) or an ultrasonic (n = 19) device. Operative data, histology and 90-day
complication rates were compared between the groups using analysis of variance (ANOVA) and Pearson's
chi-squared test.
Results: The two groups did not differ significantly in terms of age, body mass index, parenchymal
steatosis/inflammation or number of segments resected. A shorter time of parenchymal transection was
noted for the bipolar compression device (median: 35 min; range: 20–65 min) vs. the ultrasonic device
(median: 55 min; range: 29–75 min) (P < 0.001). Median total operative time was also shorter using the
bipolar compression device (130 min) than the ultrasonic device (180 min) (P = 0.050). No significant
differences between device groups were noted for estimated blood loss, complications of any type or
liver-specific complications.
Conclusions: Bipolar compression devices may offer advantages over ultrasonic devices in terms of
decreased transection time and total operative time. No differences in postoperative complications in
laparoscopic liver resection emerged between patients operated using the devices.
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Introduction
Recent reports and consensus statements continue to demonstrate
the safety, minimal mortality and low morbidity rates associated
with hepatic resection.1 In part, better outcomes can be attributed
to advances in techniques for parenchymal transection, which
have facilitated a reduction in transection-related blood loss.2,3
The mode of parenchymal transection in hepatic resection
has been a topic of great debate for decades and a multitude of
different techniques and technologies have been available to
surgeons. Hepatic resections have now evolved from strictly
open operations into laparoscopic4 and robot-assisted5 proce-
dures. Morbidity and mortality after hepatic resection have pro-
gressively decreased over the years as a result of improvements in
equipment, operative technique6 and anaesthesia management.7
The subsequent expansion in the volume of procedures con-
ducted means patients can now be offered resection at centres that
are committed to excellence in liver surgery. Prior to 1980, morta-
lity rates were reported to be in the 10–20% range and many
deaths were related to perioperative haemorrhage.8 Perioperative
DOI:10.1111/j.1477-2574.2011.00414.x HPB
HPB 2012, 14, 126–131 © 2012 International Hepato-Pancreato-Biliary Association
mortality has since dropped significantly to approximately 5%.8
The clamp-crush technique, first reported in 1974, has been used
for decades and remains the standard means of parenchymal divi-
sion for many surgeons.9 Control of intraoperative haemorrhage
has been one of the principle technical challenges in advancing
liver surgery. Excessive blood loss and intraoperative blood trans-
fusions have been shown to be associated with increased periop-
erative mortality and morbidity,10 including an increased rate of
hepatocellular carcinoma recurrence.11 Transfusions are also asso-
ciated with increased postoperative infection and with increased
cost.12 The overall cost of blood transfusions in surgical patients
was recently examined. Each red blood cell unit was found to cost
US$522–1183 when all major processes to preserve and adminis-
ter blood were considered.13
Many devices for the division of the liver parenchyma in both
open and minimally invasive surgery are now available to sur-
geons (Table 1). These devices include the bipolar compression
device (a device that uses bipolar energy and pressure in order to
fuse collagen and elastin within the tissue), which has been shown
to be safer for the patient and less expensive to use.11 However,
studies have reported that ultrasonic energy devices shorten
operative time and decrease postoperative complications.13,14
The goal of this study was to compare the operative outcomes
of laparoscopic hepatic transection performed using the bipolar
compression and ultrasonic devices, respectively.
Materials and methods
A prospective hepatopancreatobiliary database for patients oper-
ated from December 2002 to August 2009 at the University of
Louisville was analysed. This study identified 54 consecutive
patients who underwent laparoscopic liver resection with
parenchymal division using either a bipolar compression device
(Enseal®; Ethicon Endo-Surgery, Inc., Cincinnati, OH, USA)
(n = 35) or an ultrasonic scalpel (Harmonic Scalpel®; Ethicon
Endo-Surgery, Inc.) (n = 19).
The Harmonic Scalpel® utilizes the ultrasonic vibration of two
blades to cause the destruction of hydrogen bonds. This disrup-
tion of hydrogen bonds causes protein denaturization, coagulat-
ing small vessels of <3 mm in diameter. The parenchyma is then
cut by the saw-like motion of the device’s blades.15
The senior author (RCGM) at the Louisville Medical Center
performed all operations. The decision to use the bipolar over the
ultrasonic device or vice versa was made at the discretion of the
treating surgeon, who took the complexity of the operation and
the level of comorbidities in the patient into account when decid-
ing whether the operation should be performed laparoscopically,
as well as the availability of the device at a certain hospital. Each
device was only available at a certain hospital and thus the deci-
sion of which device to use was not influenced by the surgeon. The
surgical technique has been published previously; in short, the
abdomen is explored laparoscopically and the liver is mobilized
and surveyed using laparoscopic ultrasound.3 The line of transec-
tion is identified and marked with electrocautery. Inflow may be
occluded via intermittent Pringle application and the liver paren-
chyma is transected using a combination of haemostatic assisting
devices, clips and vascular staplers. In the majority of patients,
inflow and outflow are controlled intraparenchymally during
parenchymal transection.
In this cohort of hepatic resection patients, anatomic seg-
mental resections were performed and classified as described by
Couinaud.16 The group agreed to and used the recent Society of
Surgical Oncology and the American Hepato-Pancreatico-Biliary
Association Consensus Conference definition of resectability,
defined as allowing the resection of all visible disease and the
leaving of enough liver for an appropriate recovery time.1
Standard preoperative evaluation of patients with metastatic
colorectal cancer included three-phase computed tomography
of the abdomen and pelvis, and chest X-ray. Prior systemic
chemotherapy of any type and duration was not regarded as indi-
cating exclusion from laparoscopic resection and did not influ-
ence the choice of device utilized for parenchymal transection.
Table 1 Reported comparisons of different transection devices for hepatectomy
Authors Year Patients, n Devices compared Conclusions from study
Torzilli et al.25 2008 76 Monopolar floating ball (MFB) vs. bipolar
forceps (BF)
MFB has no significant benefit over BF
Jagannath et al.21 2010 NS Multiple instruments No convincing evidence for the superiority
of any single technique
Nanashima et al.14 2010 33 Combination of crush clamping and
vessel sealing
Safe and allows rapid completion
Burdio et al.24 2003 8 Radiofrequency-assisted device Reduced blood loss
Gehrig et al.26 2011 14 LigaSure vs. conventional LigaSure is feasible and safe and may lead
to reduction in cost
Lesurtel et al.28 2005 100 Crush clamp vs. compact ultrasonic
surgical aspirator (CUSA) vs. hydrojet
Crush clamp was the most efficient device
in terms of resection time, blood loss and
blood transfusion
Takayama et al.29 2001 132 Crush clamp vs. ultrasonic dissection No difference in techniques
NS, not significant.
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Radiofrequency ablation was performed in patients with bilobar
disease, in whom the treating surgeon attempted to spare more
normal, non-tumour-bearing parenchyma and performed the
procedure using intraoperative ultrasonography guidance in order
to achieve an ablation margin of 1 cm around the tumours.3,17
The technique for anaesthetic management during hepatectomy
has been previously reported.3 In principle, low central venous
pressure (<5 mmHg) was achieved and urine output of 25 ml/h
and systolic blood pressure of >90 mmHg maintained during
parenchymal transection. In the event that a synchronous colonic
resection was planned, the liver resection was performed first so
that the central venous pressure could be normalized during the
subsequent colonic resection. Packed red blood cells and autolo-
gous blood were given to maintain a haemoglobin level >10 g/dl
in patients with evidence of either coronary or cerebrovascular
disease. Intraoperative blood products were not administered until
blood loss exceeded 25% of total blood volume.
Outflow control of the hepatic veins, defined by the encircling
of the vein with a short umbilical tape or complete dissection to
allow for ease of control if needed, was performed prior to paren-
chymal division in all lobectomies or extended resections. The
liver parenchyma was divided using the selected device with staple
transection of major inflow and outflow vasculature. Intermittent
inflow vascular occlusion (the Pringle manoeuvre)18 was used and
applied for intervals of 5–10 min, released briefly and reapplied
as necessary. Pringle time was recorded as the total cumulative
Pringle time applied during parenchymal transection.
Postoperative complications and length of hospital stay were
recorded and graded using a previously reported standard classi-
fication scale of complications.3,19,20 For patients with more than
one complication, in-hospital and 90-day postoperative compli-
cations were compared according to the complication with the
highest severity for each patient.20 Earlier cardiac history was
defined as history of angina, previous coronary artery disease
defined by cardiac catheterization, previous myocardial infrac-
tion, cardiac valve dysfunction requiring medication, or a history
of congestive heart failure or tachyarrhythmia. Earlier pulmonary
disease history was defined by an abnormal pulmonary function
test, history of asthma requiring daily metre-dosed inhalers, or a
history of tobacco use of >25 pack-years. All patients were
reviewed and classified using a preoperative clinical risk prog-
nostic scoring system defined for colorectal metastases.18 This
5-point, preoperative, clinical scoring system evaluates patients on
five factors: a disease-free interval of <12 months; carcinoembry-
onic antigen (CEA) >200 ng/ml; the presence of lymph node-
positive primary disease; the presence of more than one hepatic
lesion, and the presence of a hepatic lesion >5 cm in size. Opera-
tive data, histology and 90-day complication rates were compared
in order to investigate differences in outcomes between paren-
chymal transection devices.
Analysis of variance (anova), Pearson’s chi-squared test and
the Mann–Whitney U-test for normal, continuous and ordinal
variables were used to evaluate the associations of independent
variables with surgical completion. Proportional hazards analysis
was performed on all variables found significant by univariate
analysis. Relative risk (RR) with a 95% confidence interval was
calculated as a measure of association. Analyses were performed
using jmpVersion 9.0 (release 2008) (SAS Institute, Inc., Cary, NC,
USA). P-values of <0.050 were considered to indicate statistically
significant differences.
Results
Fifty-four patients underwent laparoscopic liver resection with
parenchymal division using either a bipolar compression device
(n = 35, 65%) or an ultrasonic device (n = 19, 35%) (Table 2). The
two groups were similar in terms of age, body mass index (BMI),
parenchyma steatosis/inflammation, number of Couinaud
segments resected, and distribution of abnormal parenchyma.
Median operative blood loss was 100 ml (range: 20–1000 ml) in
procedures performed using the bipolar compression device and
175 ml (range: 50–700 ml) in procedures performed using the
ultrasonic device (P = 0.580).
Median time for parenchyma transection was 35 min (range:
20–65 min) in the bipolar compression device group and 55 min
(range: 29–75 min) in the ultrasonic device group (P < 0.001)
(Table 3). Median total operative duration was 130 min (range:
70–180 min) in the bipolar compression device group and
180 min (range: 80–240 min) in the ultrasonic device group
(P = 0.050) (Table 3).
When complications in the two groups were examined
post-surgery, there were no significant differences in terms of
estimated blood loss (EBL), complications of any type or liver-
specific complications (postoperative haemorrhage or bile leak)
(Tables 3 and 4).
Discussion
New techniques, such as laparoscopic liver resection, have been
proven as effective and safe for the treatment of cancers that are
occurring at increasing incidences.3 At least 10 different tech-
niques are available, but no convincing data evidencing the supe-
riority of any single technique have emerged.21 The current study
compared two devices used for liver resection, primarily because
these devices: (i) were readily available within local institutions;
(ii) have minimal set-up requirements, and (iii) have been
established as effective in other gastrointestinal operations. Data
from the current study showed no significant differences among
patients in terms of age, BMI, parenchyma steatosis/inflammation
or number of Couinaud segments resected. In addition, when
postoperative outcomes were examined, no significant differences
between the two devices used emerged. No differences were found
in blood loss, complications of any type or liver-specific com-
plications, such as haemorrhage or bile leak.
However, the data did show clinically significant differences
between the techniques in median operative time and transection
time (Table 3). Based on these data, bipolar compression devices
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may offer advantages of decreased transection time and total
operative time over ultrasonic devices without causing any differ-
ence in rates of postoperative complications during laparoscopic
liver resection. Other potential advantages of the bipolar compres-
sion device include less thermal spread. This is particularly ben-
eficial in preventing collateral damage to surrounding structures,
as well as the operating surgeon’s hands, in hand-assisted laparo-
scopic liver resection.
The issue of which means of technology in parenchymal divi-
sion is safest and most efficacious in open and minimally invasive
Table 2 Clinical and demographic data for patients undergoing laparoscopic hepatectomy using either the bipolar compression device or the
ultrasonic device
Characteristics Bipolar compression device Ultrasonic device
(n = 35) (n = 19) P-value
Age, years, median (range) 63 (42–83) 57 (29–81) 0.092
Gender, n 17 male 11 male 0.114
18 female 8 female
Cardiac history, n 7 2 0.084
Pulmonary history, n 5 2 0.121
Diabetes, n 6 9 0.142
Alcohol history, n 6 8 0.063
Past surgical history, n 0.523
Hysterectomy (abdominal), n 4 3
Cholecystectomy, n 4 3
Colectomy, n 4 5
Appendectomy, n 4 1
BMI, median (range) 28.0 (21.1–38.0) 28.3 (1.8–43.7) 0.914
BMI, body mass index.
Table 3 Operative characteristics and postoperative outcomes in each device group
Characteristics Bipolar compression
device (n = 35)
Ultrasonic
device (n = 19)
P-value
Major hepatectomy (3 segments), n 21 11 0.912
Specific hepatectomy, n 0.042
Right lobectomy 9 16
Left lobectomy 8 2
Left lateral-segmentectomy 18 5
Other 1 2
Concomitant laparoscopic procedure, n 0.313
Colectomy 2 1
Diaphragm 2 0
Stomach 1 0
Adrenal 1 0
Small bowel 1 0
Abnormal parenchyma, n 28 17 0.504
Estimated blood loss, ml, median (range) 100 (20–1000) 175 (50–700) 0.584
Transection time, min, median (range) 35 (20–65) 55 (29–75) <0.001
Operative time, min, median (range) 130 (70–180) 180 (80–240) 0.0501
Pringle time 0 0 (0-9)
Complication, any type, n 9 2 0.211
Bile leak, n 1 0 0.531
Length of stay, days, median (range) 8 (3–33) 9 (3–28) 0.743
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hepatic surgery is controversial.21 Because parenchymal transec-
tion, especially in laparoscopic liver resection, can have the great-
est impact on intraoperative blood loss, blood transfusion,
postoperative bleeding, bile leak and survival, this topic remains
under scrutiny.22
A number of randomized controlled trials (RCTs), as well as
retrospective reviews, have looked at the safety and efficacy of
many techniques and technologies in open hepatic resection
(Table 1).14,21,23–26 Some studies show limited differences in post-
operative outcomes;27 however, in one RCT, the clamp-crush tech-
nique with continuous inflow occlusion was shown to be superior
to other technologies in terms of blood loss, transection time and
overall cost.28 This analysis sought to determine whether either
of the dissecting devices, the Harmonic Scalpel® or the Enseal®
without inflow occlusion, would provide benefits in terms of
blood loss, blood transfusion, operative time or hospital stay
amongst other variables, while decreasing the occurrence of post-
operative complications, in the laparoscopic setting.
The decrease in EBL in the Harmonic Scalpel® cohort may be
explained by the fact that the Harmonic Scalpel® requires a great
crush before coagulation can occur, whereas, by contrast, the
Enseal® allows for the gradual compression and desiccation of the
tissue followed by a potentially more robust seal and coagulation.
The present experience proved the Enseal® to be a good primary
device, allowing for the coagulation of vessels. Median EBL in the
current study compares favourably with EBL data in other studies
looking at single-device29 and two-device30,31 parenchymal divi-
sion, in which EBL ranges from 300 ml to >1000 ml.
Although median operative time was shorter in the bipolar
compression device group, the difference between groups did not
reach statistical significance, perhaps because of the small sample
size. This use of the bipolar compression device appears to provide
comparable or faster operative times than the clamp-crush tech-
nique and the dissecting sealer technique, as previously reported
in patients undergoing major open resection in other groups.22
The complication of bile leaks in liver resection is always wor-
risome and may be affected by the device chosen for parenchymal
transection. Studies have produced conflicting data regarding the
occurrence of bile leak with the Harmonic Scalpel®. One study
reported biliary fistula rates as high as 24% with the Harmonic
Scalpel®, compared with a rate of 7% with the clamp-crush tech-
nique.32 This reportedly high fistula rate was clearly concerning in
the evaluation of a new device, but was not observed in this study,
which showed a very low biliary leak rate of 1%.
The limitations of this study include its relatively small sample
size and its retrospective nature; however, it remains the largest
review of the laparoscopic use of haemostatic transaction devices.
In addition, this study was not a randomized trial; however, the
surgical team was similar throughout the study period, which
removes some variability from the study. In addition, the surgeon
who performed these operations can be expected to have experi-
enced a learning curve bias and to have become more comfortable
with laparoscopic hepatic resections over time; however, both
devices were used during the most recent time period evaluated.
Conclusions
In conclusion, the findings of this study indicate that bipolar
compression devices may offer advantages over ultrasonic devices
in terms of decreased transection time and shorter total operative
time. Rates of postoperative complications during laparoscopic
liver resection do not differ between the two modalities.
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